CASI CLINICI – Case Reports
Volume:
Biochimica Clinica, 48 (4) pag e34-e37
Pubblicato on-line:
Settembre 17, 2024
DOI:
10.19186/BC_2024.040
An erytropoietin measurement difficult to interpret
AUTORI
ABSTRACT
Erythropoietin (EPO) regulates red blood cell production and is mainly produced in the peritubular cells of the adult kidney in response to a decrease in tissue oxygenation. EPO determination is requested in cases of reduced or increased erythrocyte production. Laboratory assays used to measure EPO in human serum are mainly based on enzyme-linked immunosorbent assays (ELISA). ELISA results, however, may be affected by the presence of heterophile antibodies. We report a case of analytical interference in EPO measurement.
BIBLIOGRAFIA
Wauthier L, Plebani M, Favresse J. Interferences in immunoassays: review and practical algorithm. Clin Chem Lab Med 2022;60:808-20.
Jacobson Lo, Goldwasser E, Fried W, Plzak L. Role of the kidney in erythropoiesis. Nature 1957;179:633-4.
Elliott S, Pham E, Macdougall IC. Erythropoietins: a common mechanism of action. Exp Hematol 2008;36:1573-84
Koury MJ, Bondurant MC. The mechanism of erythropoietin action. Am J Kidney Dis 1991;18 Suppl 1:20-3.
Marsden JT. Erythropoietin, measurement and clinical applications. Ann Clin Biochem 2006;43:97-104
Morton A. When lab tests lie … heterophile antibodies. Aust Fam Physician 2014;43:391-3.
Zhang J, Xu L, Qiao L. Falsely elevated serum estradiol in woman of reproductive age led to unnecessary intervention and delayed fertility opportunity: a case report and literature review. BMC Womens Health 2022;22:232.
Altinier S, Varagnolo M, Zaninotto M, Boccagni P, Plebani M. Heterophilic antibody interference in a non-endogenous molecule assay: an apparent elevation in the tacrolimus concentration. Clin Chim Acta 2009;402:193-5.
Vanderstichele H, Stoops E, Vanmechelen E, Jeromin A. Potential sources of interference on Abeta immunoassays in biological samples. Alzheimers Res Ther. 2012;4:39.
Sturgeon CM, Viljoen A. Analytical error and interference in immunoassay: minimizing risk. Ann Clin Biochem 2011;48:418-32.
Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab 2013;27:647-61.
Marcolla A, Dilberis C, Dal Bosco F, Amadori P. Impatto clinico e laboratoristico delle isoforme macromolecolari della prolattina, RIMeL – IJLaM 2005;2:123-9.
